Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Drug Metabolism and Pharmacokinetics
|
January 30, 2013
Three-dimensional quantitative structure-activity relationship analysis of inhibitors of human and rat cytochrome P4503A enzymes
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, et al.
Drug Metabolism and Pharmacokinetics
|
July 17, 2013
In silico study on the inhibitory interaction of drugs with wild-type CYP2D6.1 and the natural variant CYP2D6.17
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, et al.
Pharmacology Research & Perspectives
|
June 4, 2015
Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
Gen Li, Izumi Nakagome, Shuichi Hirono, et al.
Journal of Pharmaceutical Sciences
|
November 11, 2014
Three-dimensional quantitative structure-activity relationship analysis for human pregnane X receptor for the prediction of CYP3A4 induction in human hepatocytes: structure-based comparative molecular field analysis
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, et al.
Molecular Nutrition & Food Research
|
October 31, 2012
Genistein and daidzein, typical soy isoflavones, inhibit TNF-α-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes
Masayoshi Yanagisawa, Masahiro Sugiya, Hiroshi Iijima, et al.
Pharmaceutical Research
|
March 24, 2005
Estimation of the three-dimensional pharmacophore of ligands for rat multidrug-resistance-associated protein 2 using ligand-based drug design techniques
Shuichi Hirono, Izumi Nakagome, Rie Imai, et al.
Biophysical Chemistry
|
July 12, 2017
In silico analyses of the effects of a point mutation and a pharmacological chaperone on the thermal fluctuation of phenylalanine hydroxylase
Daichi Hayakawa, Noriyuki Yamaotsu, Izumi Nakagome, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
March 8, 2019
[Identifying Inhibitors of USP7-HDM2 Protein-Protein Interaction (PPI) by the in Silico Fragment-mapping Method]
Kensuke Misawa, Shin-Ichiro Ozawa, Tomoki Yoshida, et al.
Glycobiology
|
April 13, 2019
Characterizing the selectivity of ER α-glucosidase inhibitors
Sarah O'Keefe, Quentin P Roebuck, Izumi Nakagome, et al.
Journal of Molecular Graphics & Modelling
|
January 28, 2017
Multi-step virtual screening to develop selective DYRK1A inhibitors
Tomoko Koyama, Noriyuki Yamaotsu, Izumi Nakagome, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Drug Metabolism and Pharmacokinetics
|
January 30, 2013
Three-dimensional quantitative structure-activity relationship analysis of inhibitors of human and rat cytochrome P4503A enzymes
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, et al.
Drug Metabolism and Pharmacokinetics
|
July 17, 2013
In silico study on the inhibitory interaction of drugs with wild-type CYP2D6.1 and the natural variant CYP2D6.17
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, et al.
Pharmacology Research & Perspectives
|
June 4, 2015
Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
Gen Li, Izumi Nakagome, Shuichi Hirono, et al.
Journal of Pharmaceutical Sciences
|
November 11, 2014
Three-dimensional quantitative structure-activity relationship analysis for human pregnane X receptor for the prediction of CYP3A4 induction in human hepatocytes: structure-based comparative molecular field analysis
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, et al.
Molecular Nutrition & Food Research
|
October 31, 2012
Genistein and daidzein, typical soy isoflavones, inhibit TNF-α-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes
Masayoshi Yanagisawa, Masahiro Sugiya, Hiroshi Iijima, et al.
Pharmaceutical Research
|
March 24, 2005
Estimation of the three-dimensional pharmacophore of ligands for rat multidrug-resistance-associated protein 2 using ligand-based drug design techniques
Shuichi Hirono, Izumi Nakagome, Rie Imai, et al.
Biophysical Chemistry
|
July 12, 2017
In silico analyses of the effects of a point mutation and a pharmacological chaperone on the thermal fluctuation of phenylalanine hydroxylase
Daichi Hayakawa, Noriyuki Yamaotsu, Izumi Nakagome, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
March 8, 2019
[Identifying Inhibitors of USP7-HDM2 Protein-Protein Interaction (PPI) by the in Silico Fragment-mapping Method]
Kensuke Misawa, Shin-Ichiro Ozawa, Tomoki Yoshida, et al.
Glycobiology
|
April 13, 2019
Characterizing the selectivity of ER α-glucosidase inhibitors
Sarah O'Keefe, Quentin P Roebuck, Izumi Nakagome, et al.
Journal of Molecular Graphics & Modelling
|
January 28, 2017
Multi-step virtual screening to develop selective DYRK1A inhibitors
Tomoko Koyama, Noriyuki Yamaotsu, Izumi Nakagome, et al.
Page
of 3